Will Novavax Stock Jump Another 25% This Year?
Novavax (NASDAQ: NVAX) ranked as the best-performing COVID-19 vaccine stock in 2020. It's off to a fantastic start in 2021 as well with a triple-digit-percentage gain. In this Motley Fool Live video recorded on Feb. 3, Fool.com contributors Keith Speights and Brian Orelli discuss whether or not Novavax stock can tack on another 25% this year.
Source Fool.com